Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Opicapone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,852Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Opicapone: New COMT Inhibitor Transforms Parkinson's Treatment
    Opicapone: New COMT Inhibitor Transforms Parkinson's Treatment

    09 Apr 2025

    // PRESS RELEASE

    https://www.suanfarma.com/apis-3/a-next-gen-ally-in-parkinsons-care-opicapone-the-powerful-comt-inhibitor/

    PRESS RELEASE
    09 Apr 2025
    Share Share
    Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)
    Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)

    07 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231207320607/en

    BUSINESSWIRE
    07 Dec 2023
    Share Share
    Neurocrine Presents Parkinson's Disease Patient Characteristics From ONGENTYS
    Neurocrine Presents Parkinson's Disease Patient Characteristics From ONGENTYS

    24 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-real-world-parkinsons-disease-patient-characteristics-from-ongentys-opicapone-open-label-study-at-ana2022-301656404.html

    PRNEWSWIRE
    24 Oct 2022
    Share Share
    Neurocrine Presents Analysis of ONGENTYS Capsules Effect on COMT Activity
    Neurocrine Presents Analysis of ONGENTYS Capsules Effect on COMT Activity

    15 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-new-post-hoc-analysis-of-ongentys-opicapone-capsules-effect-on-comt-activity-at-the-2022-mds-international-congress-301624809.html

    PRNEWSWIRE
    15 Sep 2022
    Share Share
    Bial Portela & Companhia Ontilyv (opicapone) Receives Approval in Europe
    Bial Portela & Companhia Ontilyv (opicapone) Receives Approval in Europe

    07 Mar 2022

    // EMA

    https://www.ema.europa.eu/en/documents/overview/ontilyv-epar-medicine-overview_en.pdf

    EMA
    07 Mar 2022
    Share Share
    Bial Portela's Biologic Optilyv (Opicapone) Receives Approval in Europe
    Bial Portela's Biologic Optilyv (Opicapone) Receives Approval in Europe

    07 Mar 2022

    // EMA

    https://www.ema.europa.eu/en/medicines/human/EPAR/ontilyv

    EMA
    07 Mar 2022
    Share Share